Shutting out China’s best minds will only push them into a homegrown Chinese research ecosystem that is eclipsing American ...

Liberal Socialism is Worth Your Consideration Matt McManus has been a unique Left writer for years, prominent for extensive reviews debunking various ...

NYC MAYORAL RACE: Three candidates for mayor of New York faced off tonight for their first debate of the general election: ...

In two decades, the app has grown from a user-generated circus into the most powerful platform on earth. CEO Neal Mohan on ...

Nigeria’s Journey and the Boko Haram Conundrum", General Irabor dives into Nigeria's challenging journey to end the Boko ...

Tell City had a population of 7,700 in 2001 (it’s not much different now), compared to NYC’s 8 million). To put it into ...

A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk ...

In “Replaceable You,” Mary Roach describes mind-boggling efforts to replace human body parts—and why it’s proven to be so ...

CENTRAL VALLEY — Coincidentally, the same approach that Warwick used in overcoming a considerable deficit, was also applicable to Angelika Quadrino's celebratory dinner. "You don't have to get it all ...

Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types ...

Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...